Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Other ETFs median (73 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 11 Oct 2022 – 20 Aug 2026, limited by HDFC NIFTY100 Low Volatility 30 ETF. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | HDFC NIFTY100 Low Volatility 30 ETF | Nifty 100 |
|---|---|---|
| 11 Oct 2022 | ₹100.00 | ₹100.00 |
| 05 Feb 2023 | ₹104.44 | ₹102.32 |
| 03 Jun 2023 | ₹111.36 | ₹106.78 |
| 28 Sep 2023 | ₹118.65 | ₹112.53 |
| 24 Jan 2024 | ₹137.35 | ₹125.80 |
| 20 May 2024 | ₹143.63 | ₹135.63 |
| 15 Sep 2024 | ₹169.98 | ₹152.84 |
| 10 Jan 2025 | ₹154.86 | ₹139.22 |
| 07 May 2025 | ₹156.11 | ₹143.97 |
| 02 Sep 2025 | ₹165.60 | ₹145.87 |
| 28 Dec 2025 | ₹170.73 | ₹153.82 |
| 25 Apr 2026 | ₹158.34 | ₹143.63 |
| 20 Aug 2026 | ₹165.55 | ₹146.89 |
| Metric | HDFC NAV ₹20.86 Very High risk ★★★★☆ | Category median Other ETFs · 73 funds |
|---|---|---|
| -0.28% | +4.04% | |
| +11.85% | +10.87% | |
| — | +9.30% | |
| — | +11.96% | |
| +13.96% | +11.34% | |
| +9.19% | — | |
| +14.96% | +14.16% | |
| — | +14.63% | |
| — | +13.16% | |
| Risk | ||
| 11.59% | 14.74% | |
| 0.46 | 0.30 | |
| 0.65 | 0.42 | |
| -18.16% | -21.01% | |
| Nifty 100 | — | |
| +2.33% | +0.59% | |
| 0.93 | 1.00 | |
| 96.3% | 100.9% | |
| 79.8% | 97.8% | |
| 0.30% | 0.29% | |
| ₹12.28Cr | ₹143.12Cr | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| Arun Agarwal | — | |
| 11 Oct 2022 | — | |
| 30 | — | |
| 36.9% | — | |
| — | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.